| |
|


"We don't send out any CBCs. We use our LaserCyte®
machine 24 hours a day to support this clinic and our
two outside clinics, because the more we do in-house, the better it is
for our patients. I have 100% confidence in this instrumentthe
speed, the accuracy and the great maintenance."
|
|
|
Hematology thought leaders, IDEXX
LaserCyte® customers convene at
IDEXX
The latest advances in veterinary hematology were the topic of
the week at IDEXX headquarters in Westbrook, Maine, recently when
academic experts from around the world met up with IDEXX LaserCyte® Hematology Analyzer customers at
the third IDEXX Hematology Summit in November. Scheduled events
included presentations and discussion sessions, with attendees also
taking time for an IDEXX tour and open house with employees.
"There was an interesting dialogue between the thought leaders
and our customers," said Hematology Marketing Manager, Brad
Brazell. "We learned a lot about how to address the
educational needs of the veterinary communityhow we can bridge
the gap between what practitioners know and what they want to
learn."


|
|
 |
Featured Case Study: Hemolytic
Anemia in a Cat
Signalment: Two-year-old, intact female, domestic
shorthair cat named Tiffany
Clinical Presentation: Tiffany presented with a
sudden onset of depression and anorexia. A mild heart murmur,
difficult to characterize during auscultation, was detected, but
beyond the relatively severe depression, no obvious physical
abnormalities were noted.
In-House Laboratory Findings
Initial CBC Data Assessment:
Red Blood CellsThere was
a moderately severe, normocytic and normochromic anemia of
unidentified etiology. The potential of an inappropriate nucleated red
blood cell response associated with bone marrow stromal damage was
strongly considered since there was no morphologic support for strong
regenerative anemia (normal MCV and MCHC) that would justify the
degree of nucleated red blood cell response.
White Blood CellsThere
was a mild leukocytosis characterized by a mature neutrophilia,
monocytosis and a basophilia. Changes were most consistent with an
inflammatory process associated with a peripheral demand for
macrophages (monocytosis).
Plateletswere too
clumped to allow accurate enumeration.
Complete Blood Count Results
| Test |
Result |
Units |
Reference Range |
| RBC |
3.13 |
x106/µL |
6.010.0 |
| Hgb |
5.1 |
g/dL |
9.515 |
| Hct |
14.8 |
% |
2945 |
| MCV |
48 |
fL |
4158 |
| MCHC |
34.2 |
g/dL |
2936 |
| nRBC |
204 |
/100 WBC |
02 |
| WBC |
22.1 |
x103/µL |
4.215.6 |
| Neutrophils |
12.9 |
x103/µL |
2.512.5 |
| Lymphocytes |
5.6 |
x103/µL |
1.57.0 |
| Monocytes |
2.5 |
x103/µL |
0.85 |
| Eosinophils |
0.21 |
x103/µL |
01.5 |
| Basophils |
0.9 |
x103/µL |
01.1 |
| Platelets |
Clumped |
x103/µL |
170600 |
| Reticulocyte |
316,130/µL |
50,000µL |
CBC Data Assessment in Conjunction with a Peripheral
Blood-Film Review
(Visit
the March 2004 Diagnostic Edge for tips on creating a
high-quality blood smear)
Figure 1.

Figure 2.
 |
Red Blood CellsFigure 1 and
Figure 2, representing a peripheral blood film, illustrate that
Tiffany had a strongly regenerative, moderately severe anemia most
likely associated with hemolytic disease, based upon the degree of the
polychromasia. A manual reticulocyte count of 316,130/µL (normal
50,000/µL) provided objective data to support this
interpretation. Specific cause for the anemia was not identified;
however, a possible immune-mediated component was suspected because of
the suggestion of red blood cell agglutination. No infectious
etiologic agents were identified; however, underlying Mycoplasma
haemofelis (previously Hemobartonella) was maintained
high in the differential diagnosis list.
The presence of high numbers of nucleated red blood cells was also
confirmed; the degree of polychromasia was much greater than the
degree of metarubricytosis, suggesting that primary bone marrow
stromal damage was not the cause for the nucleated red blood cell
response.
White Blood CellsLeukocyte
distribution as reported in the CBC was validated. No significant
leukocyte morphologic abnormalities were noted.
PlateletsFigure 1 and
Figure 2 show platelets appearing adequate in number, but as mentioned
in the initial data presentation, an accurate enumeration of platelets
was not possible because of platelet clumping. Enlarged platelet forms
were present, but this is an equivocal finding in the peripheral blood
of cats. It may be associated with accelerated thrombopoiesis at the
marrow level in response to a peripheral demand for platelets.
Clinical Outcome:
Tiffany was treated with both antibiotic therapy specifically
directed against Mycoplasma haemofelis, and immunosuppression
to specifically address the probable immune-mediated component to the
anemia. Tiffany's clinical condition worsened and the owners elected
for euthanasia.
Significant Points Related to This Case:
An absolute reticulocyte
count and peripheral blood-film evaluation identifying the marked
polychromasia, which correlates with the reticulocyte count, was
essential in properly characterizing this anemia as strongly
regenerative and; therefore, probably hemolytic in origin. The lack of
an increased MCV and a decreased MCHC, which is commonly seen with
regenerative anemia, could be misleading if interpreted without the
reticulocyte count or blood-film evaluation. Many strongly
regenerative anemias, or cases where there is a significant
reticulocytosis for other reasons, will have high or low normal MCV
and MCHC values, respectively, or will actually have MCV and MCHC
values outside of the reference range. The presence of significant
numbers of reticulocytes in circulation forces these values in their
respective directions because these immature red blood cell forms are
larger than mature red blood cells and have less hemoglobin content.
The primary problem with using these parameters as the sole method of
differentiating regenerative from nonregenerative anemia is that they
only represent the "mean" cell volume and cell hemoglobin
concentration. There may be an adequate reticulocyte response to
justify calling an anemia regenerative even though the "mean" of all
the circulating erythrocytes does not change enough to bring the
values out of the reference range. In addition, there are clinical
situations where increased MCV (myelodysplasia) and decreased MCHC
(developing iron deficiency) may be seen when there is no evidence of
a "regenerative" picture.
The reticulocyte count is considered the most objective and
reliable measure of bone marrow responsiveness to accurately classify
anemia as to its regenerative status. An added advantage of the IDEXX LaserCyte® Hematology Analyzer profile is
that an absolute reticulocyte count is provided with each canine and
feline CBC. This valuable information is immediately available to the
veterinarian, allowing him/her to answer the first and most important
question when an anemia is identified, "is it a regenerative or
nonregenerative?"
The suggestion of agglutination on the blood smear provides
additional information leading to a logical interpretation that an
immune-mediated component to this regenerative anemia may be present.
Additional testing, including performing a saline agglutination test
and possible Coombs test, would have been required to confirm this
suspicion.
Because of the high number of nucleated red blood cells present in
this case (204/100 WBC), an accurate instrument leukocyte count would
have been impossible with a simple impedance-based hematology
analyzer. The nucleated red blood cells would have been enumerated as
other nucleated cells, giving a dramatically high false value for the
leukocyte count if used without blood-film evaluation and correction
for the nucleated red blood cells. The more advanced hematology
analyzers utilize other methods such a laser-flow cytometry or enzyme
cytochemistry to avoid this limitation. Because of the laser-flow
cytometry methodology utilized by LaserCyte and the more advanced
reference laboratory analyzers, the greater detailed interrogation of
cellular elements allows easy differentiation between nucleated red
blood cells and leukocytes. An accurate leukocyte count is possible
without additional technical time to "correct" for the nucleated red
blood cells whenever they are present.
Submit
a Case Study
The recommendations contained in Diagnostic Edge
educational materials are intended to provide general guidance only.
As with any diagnosis or treatment, you should use clinical discretion
with each patient based on a complete evaluation of the patient,
including physical presentation and complete laboratory data. With
respect to any drug therapy or monitoring program, you should refer to
product inserts for a complete description of dosages, indications,
interactions and cautions.
This summary was written by Dr. Dennis B. DeNicola of IDEXX
Laboratories.
|
|
|
Question & Answer
From the canine
pancreatitis case study featured in the December
2004 Diagnostic Edge.
Question: I read the pancreatitis case study
today and followed it well until we got to the confirming test for
acute pancreatitis. I don't know what the cPLI test is. Please
enlighten me.
Answer: The test identified as cPLI is a canine
pancreas lipase immunoreactivity test developed by Dr. D. Williams
and Dr. J. Steiner in the gastroenterology laboratory at the Texas
A&M School of Veterinary Medicine. They developed this assay because
of relative nonspecificity of other parameters of pancreatic injury
that are available for detecting pancreatitis. Lipase values coming
from reference laboratory and in-clinic chemistry systems
demonstrates greater than 50% specificity of pancreatitis in the dog
when the lipase values are greater than 34 times the high end
of the reference range for that test. Although significant
additional research needs to be accomplished, the cPLI test
demonstrates greater than 80% specificity (based upon histologically
confirmed cases of pancreatitis) in the dog, and therefore, there is
significant promise for this test. The fPLI test, specific for
feline pancreatic lipase, demonstrates similar promise in Dr.
Williams' and Dr. Steiner's hands.
For your information, the following Web site can be further
investigated. This is one of the earlier references published
regarding the development of both the cPLI and the fPLI tests: www.pubmedcentral.nih.gov.
I hope this answers your question. Please remember, that the
diagnosis of pancreatitis in the dog is still somewhat difficult.
Never attempt to utilize laboratory testing by itself. The
laboratory data is merely there in conjunction with the radiographic
or sonographic changes typically seen with pancreatitis to support
our clinical impression of pancreatitis.
Dennis B. DeNicola, DVM, PhD, DACVP
Chief Veterinary Educator, IDEXX Laboratories
Michelle Kahn, MS, DVM
Medical Affairs Manager, IDEXX Laboratories
Submit
a question to our clinical pathologists.
|
|
|
|
 |
Early detection of renal disease is
now possible on the IDEXX VetTest®
Chemistry Analyzer
By the time azotemia is discovered in blood chemistries and renal
disease is diagnosed, up to 75% of an animal's kidneys may already be
destroyed. While knowing an animal has kidney disease allows you to
treat and manage the disease progression, having this knowledge before
your patient develops azotemia can be far more advantageous.
For years, researchers have looked for ways to better predict
kidney disease. Even small amounts of protein in the urine can be
abnormal, and recent research shows that persistent high urine
protein:creatinine (UPC) ratios are linked to a poor prognosis in
patients.1 The ability to quantify the level of proteinuria
in an animal's urine is being recognized as a key tool to helping
diagnose and monitor early renal disease.
This is now possible in your clinic with the IDEXX Urine P:C Ratio
the first fully quantitative measure of urinary protein loss in-house.
This convenient, fast and inexpensive new test for the VetTest® Chemistry Analyzer allows you to
diagnose early renal disease, monitor and evaluate treatment, and
alter the course of disease to enhance the lives of your patients.
|
|
Sample prep kit includes:
- 50 pipette tips
- Two pipettors (one 10-µL, one 200-µL)
- One bottle of solution
Contact your IDEXX distributor for the availability of this
special offer.
|
|
|
 |
| |
|
Education and
Events
We offer a variety of seminars and teleconferences about emerging
trends and best practices in veterinary diagnosticsin a forum
designed to involve, educate and motivate you and your staff.
LaserCyte® Analyzer User Group Session
Become a LaserCyte "super user" in just one afternoon!
Friday, January 7, 2005, 1:00 p.m. to 5:00 p.m.
Marriot World Center
8701 World Center Drive
Orlando, Florida
|
|
|
 |
Spotting Giardiainfected
dogs and cats in-clinic
Giardia is a common intestinal parasite of dogs and cats.
Infection prevalence can vary to more than 50%, depending on the
population, and up to 100% in shelters and kennels.
Unfortunately,
Giardia infection is commonly undiagnosed in the clinical
setting. Why? One reason is methodology. Clinics have depended on
microscopic evaluation of feces to identify Giardia
trophozoites or cysts. Technicians know that the fecal float can be
used to identify many internal parasites (i.e., roundworms and
hookworms), and most parasites are readily identified by any number of
in-house diagnostic microscopic methods. Giardia, on the
other hand, is almost impossible to diagnose using disposable
floatation kits.
Why is the microscopic identification of Giardia
sometimes so difficult?
Three reasons.
-
It is difficult to identify Giardia because, unlike other
parasites' eggs, the Giardia cysts are very delicate and are
often damaged beyond recognition during preparation of the slide.
-
If you're not accustomed to identifying the tiny cysts, you can
overlook them or confuse them with pollen, yeast and many other
artifacts.
-
The trophozoites and cysts only shed intermittently, which means
several fecal examinations may be necessary over several days for an
accurate result.
Until now, veterinary technicians have depended on two in-house
diagnostic techniques for identifying Giardia:
- The zinc sulfate floatation technique is used for identifying
cysts
- The trophozoites are seen occasionally on prepared fecal smears
|
Both procedures are messy, time-consuming and may have many accuracy
issues.
In 2004, IDEXX developed the SNAP® Giardia Test on the
ELISA platform because of the many problems associated with current
methods of diagnosing Giardia.
Detecting Giardia
Infection:
A Comparison of In-House Microscopy Method vs. Reference Laboratory
Methods

The SNAP Giardia Test provides many advantages for
your practice.
- Easy to set up and run so you can test for Giardia while
screening for other fecal parasites
- Only one sample is required, compared to three for
microscopymaking your workflow much faster and easier
- Includes a unique conjugate-fecal swab that allows for much
easier, "hands-off" sampling
- Fast results (just 8 minutes) so you can identify infected
patients during their visits
When should you run a SNAP Giardia Test?
- Symptomatic animals (i.e., diarrhea, weight
loss, etc.)Anytime you run a fecal float on an animal you
suspect has internal parasites, or a sick animal with semi-formed or
liquid feces
- Animals at riskAnimals from shelters and
kennels; animals that board frequently, visit doggie-daycare, or that
go hiking and camping
- Confirming Giardia findings on asymptomatic
patientsthe SNAP Giardia Test can confirm
suspect Giardia findings on healthy-pet fecal-float screens
How do you implement the SNAP Giardia Test into
your practice?
- First, have a staff meeting to notify everyone of the protocol
change, and then place a reminder to run the test near the slides and
coverslips or microscope.
- Run the SNAP test during the fecal float; all results will be
completed together.
- Change your invoice receipt or computer to include a
comprehensive fecal charge.
| Example
Invoice Printouts: |
| Comprehensive Fecal $34.00 |
Comprehensive Fecal $34.00 |
| Fecal Float |
Roundworms |
Hookworms |
| Direct Smear |
Whipworms |
Tapeworms |
| SNAP Giardia |
Coccidia |
Giardia |
|
|
|
|
 |
Calling All Qualified Urine
Protein:Creatinine/Renal Disease Case Studies
Do you have a case study
in which a urine protein:creatinine ratio helped you detect renal
disease? If so, you could win a copy of Renal Disease in Dogs and
Cats by Dr. Jonathan Elliott and Dr. Scott Brown, just for
sending us a qualified submission!
The case that best exemplifies how clinics can "practice what's
possible" will be featured in a special edition case study booklet on
renal disease and proteinuria.
Qualified submissions must include:*
- The patient's name, signalment, history, physical examination,
bloodwork and a complete urinalysis (including an IDEXX Urine P:C
Ratio result)
- A diagnosis of renal disease (either primary or secondary)
- The name, address and telephone number of your clinic; and the
names of your veterinarians and veterinary technicians
- Pictures, if possible
*Limit one case per clinic.
Cases must be submitted to the following address:
Dr. Michelle Kahn
Attention: UPC/Renal Disease Case Study
IDEXX Laboratories
One IDEXX Drive
Westbrook, Maine 04092 |
|
If you have any questions, please contact your IDEXX representative
or call Dr. Michelle Kahn at 1-207-556-8589.
|
| |
|
|
|